Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis
- PMID: 22474733
Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis
Abstract
Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that is approved for use up to 4 weeks in patients aged 18 years and older with moderate to severe plaque psoriasis. The efficacy and safety of clobetasol propionate spray 0.05% has been extensively evaluated in clinical trials in more than 2200 patients with moderate to severe plaque psoriasis. This article reviews the efficacy, safety, and tolerability of clobetasol propionate spray 0.05%. Clobetasol propionate spray 0.05% is a topical product with a documented efficacy and safety profile with good acceptability in patients with moderate to severe plaque psoriasis.
Similar articles
-
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.Cutis. 2006 Nov;78(5):348-54. Cutis. 2006. PMID: 17186795 Clinical Trial.
-
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.Cutis. 2009 Oct;84(4 Suppl):25-32. Cutis. 2009. PMID: 19916299 Clinical Trial.
-
Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.J Drugs Dermatol. 2011 Aug;10(8):885-92. J Drugs Dermatol. 2011. PMID: 21818510 Clinical Trial.
-
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.J Drugs Dermatol. 2012 Nov;11(11):1348-54. J Drugs Dermatol. 2012. PMID: 23135087 Review.
-
Clobetasol propionate for psoriasis: are ointments really more potent?J Drugs Dermatol. 2006 Jun;5(6):527-32. J Drugs Dermatol. 2006. PMID: 16774104 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical